Abbott Laboratories buy Benchmark Co.
Start price
10.10.25
/
50%
€115.06
Target price
10.10.26
€125.35
Performance (%)
-18.09%
Price
28.07.26
€94.24
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -18.09%. This prediction currently runs until 10.10.26. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 7.801% | 7.801% |
| iShares Core DAX® | 2,99 % | 3,22 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % |
| iShares S&P 500 | -0,01 % | 1,64 % |
Comments by Benchmark_Co_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€81.24
17.04.26
17.04.26
€101.90
17.04.27
17.04.27
16.00%
28.07.26
28.07.26
